» Articles » PMID: 31456179

Breast Cancer: Current Perspectives on The Disease Status

Overview
Date 2019 Aug 29
PMID 31456179
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the most frequently diagnosed cancer in women and ranks second among causes for cancer related death in women. Evidence in literature has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in TNBC and drug resistance presents major inhibitions which are also current challenges for containing the disease. Similarly, a focal point of concern is the rising rate of breast cancer incidence and mortality among the population of under developed world. In this chapter, an overview of the current practices for the diagnosis and treatment of breast cancer and associated impediments has been provided.

Citing Articles

SATB1 in cancer progression and metastasis: mechanisms and therapeutic potential.

Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W Front Oncol. 2025; 15:1535929.

PMID: 40071088 PMC: 11893431. DOI: 10.3389/fonc.2025.1535929.


Layered Double Hydroxide LDH-Loaded miR-141-3p Targets RAB10 Suppressing Cellular Autophagy to Reverse Paclitaxel Resistance in Breast Cancer.

Tao S, Ji Y, Li R, Xiao Y, Wu H, Ye R ACS Omega. 2025; 10(6):5886-5899.

PMID: 39989842 PMC: 11840594. DOI: 10.1021/acsomega.4c09755.


Identifying traditional Chinese medicine combinations for breast cancer treatment based on transcriptional regulation and chemical structure.

Li S, Zhang L, Zhang W, Chen H, Hong M, Xia J Chin Med. 2025; 20(1):23.

PMID: 39953557 PMC: 11829537. DOI: 10.1186/s13020-025-01074-5.


Intratumoral injection of two dosage forms of paclitaxel nanoparticles combined with photothermal therapy for breast cancer.

Sun L, Zuo C, Ma B, Liu X, Guo Y, Wang X Chin Herb Med. 2025; 17(1):156-165.

PMID: 39949814 PMC: 11814247. DOI: 10.1016/j.chmed.2024.06.001.


Detection of transmembrane protein 100 in breast cancer: Correlation with malignant progression and chemosensitivity.

Liu X, Zhang G, Zhao L Cytojournal. 2025; 21:65.

PMID: 39917003 PMC: 11801651. DOI: 10.25259/Cytojournal_107_2024.